arsenic glutathione Nrf2 activation ameliorates cytotoxic effects of trioxide in acute promyelocytic leukemia cells through increased levels and arsenic efflux from cells Arsenic-Based Therapeutics

541,542 Alterations in T-cell behavior result in heightened proinflammatory TH1 and TH17 responses, reduced immune monitoring affecting the elimination of infected or cancerous cells, diminished self-tolerance contributing to autoimmune conditions, and weakened natural defenses, ultimately fostering widespread inflammation

Jiang H

Late stage PD is characterised by increasing disability from drug-refractory motor and non-motor symptoms including gait and balance problems, impaired speech and swallowing, autonomic dysfunction, and cognitive decline for all of which there is currently little prospect of highly efficacious drug therapies

When labs and symptoms line up, TRT is well studied and available now including what it actually costs in Ithaca and how the therapy works

Aging isnt the problem

Current evidence does not support systemic IGF-1 elevation or GH secretagogue activity